uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
How to model temporal changes in comorbidity for cancer patients using prospective cohort data
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, UCR-Uppsala Clinical Research Center.
Kings Coll London, Sch Med, Canc Epidemiol Grp, Div Canc Studies,Res Oncol,Guys Hosp, London SE1 9RT, England.;Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden..
Ryhov Cty Hosp, Dept Urol, Jonkoping, Sweden..
Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden..
Show others and affiliations
2015 (English)In: BMC Medical Informatics and Decision Making, ISSN 1472-6947, E-ISSN 1472-6947, Vol. 15, 96Article in journal (Refereed) Published
Resource type
Text
Abstract [en]

Background: The presence of comorbid conditions is strongly related to survival and also affects treatment choices in cancer patients. This comorbidity is often quantified by the Charlson Comorbidity Index (CCI) using specific weights (1, 2, 3, or 6) for different comorbidities. It has been shown that the CCI increases at different times and with different sizes, so that traditional time to event analysis is not adequate to assess these temporal changes. Here, we present a method to model temporal changes in CCI in cancer patients using data from PCBaSe Sweden, a nation-wide population-based prospective cohort of men diagnosed with prostate cancer. Our proposed model is based on the assumption that a change in comorbidity, as quantified by the CCI, is an irreversible one-way process, i.e., CCI accumulates over time and cannot decrease. Methods: CCI was calculated based on 17 disease categories, which were defined using ICD-codes for discharge diagnoses in the National Patient Register. A state transition model in discrete time steps (i.e., four weeks) was applied to capture all changes in CCI. The transition probabilities were estimated from three modelling steps: 1) Logistic regression model for vital status, 2) Logistic regression model to define any changes in CCI, and 3) Poisson regression model to determine the size of CCI change, with an additional logistic regression model for CCI changes >= 6. The four models combined yielded parameter estimates to calculate changes in CCI with their confidence intervals. Results: These methods were applied to men with low-risk prostate cancer who received active surveillance (AS), radical prostatectomy (RP), or curative radiotherapy (RT) as primary treatment. There were large differences in CCI changes according to treatment. Conclusions: Our method to model temporal changes in CCI efficiently captures changes in comorbidity over time with a small number of regression analyses to perform - which would be impossible with tradition time to event analyses. However, our approach involves a simulation step that is not yet included in standard statistical software packages. In our prostate cancer example we showed that there are large differences in development of comorbidities among men receiving different treatments for prostate cancer.

Place, publisher, year, edition, pages
2015. Vol. 15, 96
Keyword [en]
Temporal changes, Comorbidity, Cancer, Cox proportional hazards, State transition model
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-270447DOI: 10.1186/s12911-015-0217-8ISI: 000365161100002PubMedID: 26582418OAI: oai:DiVA.org:uu-270447DiVA: diva2:898355
Funder
Swedish Research Council, 825-2008-5910
Available from: 2016-01-28 Created: 2015-12-28 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

fulltext(593 kB)123 downloads
File information
File name FULLTEXT01.pdfFile size 593 kBChecksum SHA-512
6166cc11e54fd7be4eaa38aa2cc04c304d369ac117709fab3b7e6aeb3a2db1474eae48d65fcaf87418aa5ec5c8fe14d8874b25545346ee33ecd5476dd12d47b7
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Lindhagen, LarsGarmo, Hans

Search in DiVA

By author/editor
Lindhagen, LarsGarmo, Hans
By organisation
UCR-Uppsala Clinical Research Center
In the same journal
BMC Medical Informatics and Decision Making
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 123 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 212 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf